NCT03657849View on ClinicalTrials.gov

Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 18, 2018

Primary Completion Date

January 25, 2019

Study Completion Date

August 31, 2019

Conditions
Enlarged Lymph Nodes (Excluding Infective)
Interventions
DEVICE

EBUS TBNA

All patients undergo EBUS TBNA with two needle sizes

Trial Locations (1)

55101

Regions Hospital, Saint Paul

All Listed Sponsors
lead

HealthPartners Institute

OTHER

NCT03657849 - Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy | Biotech Hunter | Biotech Hunter